Literature DB >> 28762863

Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-α to reactivate HIV-1 from latency.

Xiao-Xin Ren1,2, Li Ma1,2, Wei-Wei Sun2,3, Wen-Dong Kuang2,3, Tai-Sheng Li4, Xia Jin2, Jian-Hua Wang2,3.   

Abstract

Elucidation of mechanisms underlying the establishment, maintenance of and reactivation from HIV-1 latency is essential for the development of therapeutic strategies aimed at eliminating HIV-1 reservoirs. Microbial translocation, as a consequence of HIV-1-induced deterioration of host immune system, is known to result in a systemic immune activation and transient outbursts of HIV-1 viremia in chronic HIV-1 infection. How these microbes cause the robust HIV-1 reactivation remains elusive. Dendritic cells (DCs) have previously been shown to reactivate HIV-1 from latency; however, the precise role of DCs in reactivating HIV-1 from latently infected T-cell remains obscure. In this study, by using HIV-1 latently infected Jurkat T cells, we demonstrated that AIDS-associated pathogens as represented by Mycobacterium bovis (M. bovis) Bacillus Calmette-Guérin (BCG) and bacterial component lipopolysaccharide (LPS) were unable to directly reactivate HIV-1 from Jurkat T cells; instead, they mature DCs to secrete TNF-α to accomplish this goal. Moreover, we found that HIV-1 latently infected Jurkat T cells could also mature DCs and enhance their TNF-α production during co-culture in a CD40-CD40L-signaling-dependent manner. This in turn led to viral reactivation from Jurkat T cells. Our results reveal how DCs help AIDS-associated pathogens to trigger HIV-1 reactivation from latency.

Entities:  

Keywords:  CD40-CD40L signaling; HIV-1; TNF-α; dendritic cells; viral latency

Mesh:

Substances:

Year:  2017        PMID: 28762863      PMCID: PMC5810491          DOI: 10.1080/21505594.2017.1356535

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  60 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands.

Authors:  Angela Meier; Aranya Bagchi; Harlyn K Sidhu; Galit Alter; Todd J Suscovich; Daniel G Kavanagh; Hendrik Streeck; Mark A Brockman; Sylvie LeGall; Judith Hellman; Marcus Altfeld
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

3.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.

Authors:  Chuan Li; Hai-Bo Wang; Wen-Dong Kuang; Xiao-Xin Ren; Shu-Ting Song; Huan-Zhang Zhu; Qiang Li; Li-Ran Xu; Hui-Jun Guo; Li Wu; Jian-Hua Wang
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

6.  Stimulation of Cryptococcus neoformans isolated from skin lesion of AIDS patient matures dendritic cells and promotes HIV-1 trans-infection.

Authors:  Yan Qin; Yu-Ye Li; Ai-Ping Jiang; Jin-Feng Jiang; Jian-Hua Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-06-12       Impact factor: 3.575

7.  Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.

Authors:  Guerau Fernandez; Thomas D Zaikos; Sohrab Z Khan; Ashley M Jacobi; Mark A Behlke; Steven L Zeichner
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Authors:  Hung-Chih Yang; Sifei Xing; Liang Shan; Karen O'Connell; Jason Dinoso; Anding Shen; Yan Zhou; Cynthia K Shrum; Yefei Han; Jun O Liu; Hao Zhang; Joseph B Margolick; Robert F Siliciano
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

9.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

10.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  3 in total

1.  Dendritic cells as natural latency reversing agent: A wake-up call for HIV-1.

Authors:  T van Montfort; D Speijer; B Berkhout
Journal:  Virulence       Date:  2017-09-28       Impact factor: 5.882

Review 2.  Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination.

Authors:  Eun-Ju Ko; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2019-12-24       Impact factor: 5.048

Review 3.  Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill.

Authors:  Jan Kristoff; Charles R Rinaldo; Robbie B Mailliard
Journal:  Viruses       Date:  2019-12-28       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.